Navigation Links


Bremer at Biology News

Bremer at Biology Products
Bremer at Biology Technology
Bremer at Medicine News
Bremer at Medicine Products

Bremer Hifix Skull Pin

Description:The Hifix Skull Pin is the first skull pin to utilize cutting edges instead of a sharp, nail like, tip. Instead of crushing its way into bone the Hifix pin drills a neat path leaving the bone strong and viable providing improved initial fixation over standard skull pins. The Hifix pin is used in the bremer halo crown with Hifix pins and in the bremer 3D halo crown. Hifix pins are used for the sam...
Company:Depuy Spine
Bremer at Medicine Technology
Other TagsMajMajMajMajMaj
(Date:1/7/2009)...ort Shows 73 Percent Increase in Patients Unable t...sured Patients Visiting Hospital ERs , , SACRAM... The economic recession gripping the nation is hav...spitals, according to a newly released special rep... , , The report, which is based on a survey con...
(Date:1/7/2009)...ed to treat heart failure, slowed cell growth, stu... News) -- Digoxin, a drug used for many years to t...y also be a cancer-fighting agent, researchers rep...ssels to survive. But many of these cells are oxyg...ce a protein called hypoxia-inducible factor (HIF-...
(Date:1/7/2009)...Savings is Available at Albertsons stores througho...ho, Jan. 7 Albertson,s LLC announc... prescription discount program today by introducin...over 500 generic drugs. In addition, Albertsons h...of over 500 drugs that are already covered by this...
(Date:1/7/2009)...MILLS, Md., Jan. 7 Medif...lled weight-loss program, today announced they,ve ...EO magazine. Medifast is a 2007 and 2009 winner o...izes the 50 fastest growing companies in the Great...owth. Medifast announced on December 16, 2008 that...
Breaking Medicine News(10 mins):Health News:Economic Downturn Takes Toll on California Hospitals 2Health News:Heart Drug May Be a Cancer Fighter 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2
(Date:1/6/2009)...leading global healthcare and scientific publisher...lsevier Grand Challenge, a competition inviting re...-increasing amount of online life sciences informa...mifinalist round was held on December 15th at the ...d featured each of the nine Grand Challenge teams ...
(Date:1/6/2009)...nmental impacts and growing demand for organic oli...s of agroecosystem health in olive-growing regions...s the abundance and biodiversity of invertebrates,...ve determined that Coccinellids (ladybugs) can b...tegrated farming systems. , Coccinellids were ...
(Date:1/6/2009)...cated to the memory and scientific accomplishments... angiogenesis and vasculogenesis and shed light on...ase, the newly released special double issue (Volu...gy includes a series of papers that reflect the r...-scientists of his generation. Lymphatic Research...
(Date:1/5/2009)...rstCall/ -- BIO-key International, Inc.,(OTC Bull...ric identification,and wireless public safety, to...llege Police Department to deploy MobileCop(R), BI... law enforcement. Collin College is located in Col...ons in the Dallas, Texas,metropolitan area. , ...
Breaking Biology News(10 mins):Finalists announced in the Elsevier Grand Challenge 2Finalists announced in the Elsevier Grand Challenge 3Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Texas College Police Unit Deploys BIO-key(R) Mobile Data System 2Texas College Police Unit Deploys BIO-key(R) Mobile Data System 3Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 1Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 2Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 3Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 4Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 5Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 6Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 7Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 8Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 9Video and Photo 3A Tasigna 28R 29 Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Exist 4897 10Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti PD1 Antibody 4893 1Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti PD1 Antibody 4893 2Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti PD1 Antibody 4893 3Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti PD1 Antibody 4893 4Cardiac Science to Present at the 18th Annual CIBC World Markets Healthcare Conference 4889 1Cardiac Science to Present at the 18th Annual CIBC World Markets Healthcare Conference 4889 2Amylin Pharmaceuticals to Present at BIOCOM Investor Conference 1572 1
Other Contentsepididymisepididymisepigeneticepigeneticepigeneticepigeneticepiglottisepinephrineepinephrineepinephrineepistasisepisomeepistaticerythrocyteserythrocytes